IDXX vs RXO · P/E 40, rev $2.36B vs rev $5.74B
IDEXX Laboratories Inc (IDXX) versus RXO Inc. (RXO) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
RXO Inc. (RXO) is a trucking company listed on NYSE.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported RXO revenue for 2025-12-31 was $5.74B. Net income was -$100.0M. Revenue was up 26.2% from 2024-12-31 to 2025-12-31. RXO currently screens at market cap $4.09B.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. RXO currently screens at market cap $4.09B.
Not investment advice. Open the IDXX and RXO stock pages for the full models.
Not investment advice.